ISIN | LU1871077761 |
---|---|
Valor Number | 43375944 |
Bloomberg Global ID | CSEQEFB LX |
Fund Name | UBS (Lux) Fund Solutions II - UBS MSCI Europe Index Fund EUR A acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Subfund tracks the MSCI Europe Index as its benchmark index. The Investment Objective of the Subfund is to provide the Shareholders with a return in line with the performance of the MSCI Europe Index (the “Underlying Index”) (see description under the section “Description of the Underlying Index”). |
Peculiarities |
Current Price * | 187.32 EUR | 01.07.2025 |
---|---|---|
Previous Price * | 187.73 EUR | 30.06.2025 |
52 Week High * | 192.33 EUR | 03.03.2025 |
52 Week Low * | 161.09 EUR | 09.04.2025 |
NAV * | 187.32 EUR | 01.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 121,231,376 | |
Unit/Share Assets *** | 153,187 | |
Trading Information SIX |
YTD Performance | +8.60% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
---|---|---|
YTD Performance (in CHF) | +7.87% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
1 month | -1.36% |
02.06.2025 - 01.07.2025
02.06.2025 01.07.2025 |
3 months | +1.42% |
01.04.2025 - 01.07.2025
01.04.2025 01.07.2025 |
6 months | +7.92% |
02.01.2025 - 01.07.2025
02.01.2025 01.07.2025 |
1 year | +7.79% |
01.07.2024 - 01.07.2025
01.07.2024 01.07.2025 |
2 years | +23.36% |
03.07.2023 - 01.07.2025
03.07.2023 01.07.2025 |
3 years | +43.99% |
01.07.2022 - 01.07.2025
01.07.2022 01.07.2025 |
5 years | +72.55% |
01.07.2020 - 01.07.2025
01.07.2020 01.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.51% | |
---|---|---|
Nestle SA | 2.34% | |
ASML Holding NV | 2.18% | |
Roche Holding AG | 1.93% | |
Novartis AG Registered Shares | 1.88% | |
AstraZeneca PLC | 1.86% | |
Novo Nordisk AS Class B | 1.80% | |
HSBC Holdings PLC | 1.68% | |
Shell PLC | 1.68% | |
Siemens AG | 1.45% | |
Last data update | 30.04.2025 |
TER | 0.16% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.11% |
Ongoing Charges *** | 0.11% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |